Brief: ADAR1 Capital Management Calls For Keros Therapeutics To Return $475 Mln To Stockholders By Q3
09/06/2025 20:22
June 10 (Reuters) - ADAR1 Capital Management: ADAR1 CAPITAL MANAGEMENT : CALLS FOR RETURN OF $475 MILLION TO STOCKHOLDERS BY Q3 2025 FOR KEROS THERAPEUTICS ADAR1 CAPITAL MANAGEMENT: PLANS TO NOMINATE NEW DIRECTORS FOR 2026 ANNUAL MEETING OF KEROS Further company coverage: KROS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops